PCSK9 inhibitors
A class of lipid-lowering drugs (monoclonal antibodies) that dramatically reduce LDL/apoB with essentially no side effects.
As defined in 328 - Health Longevity
Where it comes up · 3
- Peter Attia Dives Deep on STATINS (side effects & the best alternatives)6 claims
- 328 - Health Longevity3 claims
- The longevity treatment no one’s talking about: Peter Attia, M.D. | mbg Podcast2 claims
Most important claims · 10 of 11Search all claims for “PCSK9 inhibitors” →
- Statins (but not PCSK9 inhibitors, ezetimibe, or bempedoic acid) carry a small but real increased risk of type 2 diabetes, and a larger number of people become somewhat more glucose intolerant on statins—detectable via continuous glucose monitor but obscured on hemoglobin A1c—so patients showing a 5-10 point CGM change may be switched off statins despite tolerating them.328 - Health Longevity
- PCSK9 inhibitors, ezetimibe, and bempedoic acid are the three main non-statin lipid-lowering drugs: PCSK9 inhibitors reduce LDL particle clearance; ezetimibe blocks cholesterol reabsorption in the gut via the liver; and bempedoic acid is a liver-specific cholesterol synthesis inhibitor (unlike statins which act globally), with typical out-of-pocket costs of ~$500/month for PCSK9 inhibitors and bempedoic acid.The longevity treatment no one’s talking about: Peter Attia, M.D. | mbg Podcast
- PCSK9 inhibitors are approved (since 2015) and have been tested in rigorous trials, including natural experiments with individuals carrying PCSK9-loss-of-function mutations, demonstrating safety and superior efficacy compared to other lipid-lowering drugs, with zero side effects.Peter Attia Dives Deep on STATINS (side effects & the best alternatives)
- Cholesterol is essential for life but cells make enough internally without trafficking it via LDL, and people genetically lacking PCSK9 have near-unmeasurable LDL yet live perfectly fine lives, which is leading researchers to consider gene therapy to eradicate apoB-containing lipoproteins entirely.328 - Health Longevity
- Because modern drugs (statins, PCSK9 inhibitors, ezetimibe, and coming CETP inhibitors) can eradicate apoB/LDL with essentially no side effects, diet should be used to fix metabolic problems while residual lipid problems should be addressed pharmacologically rather than through diet.328 - Health Longevity
- Insurance companies typically will not cover PCSK9 inhibitors unless patients meet specific criteria such as familial hypercholesterolemia or having already had a cardiac event and being statin-intolerant.Peter Attia Dives Deep on STATINS (side effects & the best alternatives)
- PCSK9 inhibitors cost approximately $500 per month in the United States, but are cheaper outside the US; drug pricing is more favorable internationally than in the United States.Peter Attia Dives Deep on STATINS (side effects & the best alternatives)
- Lipid-lowering pharmacotherapy history: cholesterol-heart disease link identified ~1960, early treatments failed, statins introduced 1980s (~40 years ago) with benefit but high side effects, limiting prophylactic use; modern era (since ~2015) has seen development of PCSK9 inhibitors, ezetimibe, and bempedoic acid with minimal side effects.The longevity treatment no one’s talking about: Peter Attia, M.D. | mbg Podcast
- There is no justification for taking unnecessary risks with statins in high-risk individuals (those with APOE4 or family history of neurodegeneration) when alternative lipid-lowering drugs (PCSK9 inhibitors, ezetimibe, bempedoic acid) are available that do not affect brain cholesterol synthesis.Peter Attia Dives Deep on STATINS (side effects & the best alternatives)
- A physician who is not willing to prescribe PCSK9 inhibitors to appropriate patients is 'a fool' given their superior safety and efficacy, though cost and insurance barriers often prevent prescription.Peter Attia Dives Deep on STATINS (side effects & the best alternatives)